Country: Malta
Language: English
Source: Medicines Authority
CLOMIPRAMINE HYDROCHLORIDE
Novartis Ireland Limited
N06AA04
CLOMIPRAMINE HYDROCHLORIDE
COATED TABLET
CLOMIPRAMINE HYDROCHLORIDE 10 milligram(s)
POM
PSYCHOANALEPTICS
Authorised
2005-11-22
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ANAFRANIL 10MG AND 25MG COATED TABLETS ANAFRANIL 75MG SUSTAINED-RELEASE TABLETS CLOMIPRAMINE HYDROCHLORIDE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4 WHAT IS IN THIS LEAFLET 1 What Anafranil is and what it is used for 2 What you need to know before you take Anafranil 3 How to take Anafranil 4 Possible side effects 5 How to store Anafranil 6 Contents of the pack and other information 1. WHAT ANAFRANIL IS AND WHAT IT IS USED FOR WHAT ANAFRANIL IS Anafranil is available as tablets and sustained-release tablets. The active substance in Anafranil is clomipramine hydrochloride, which belongs to group of medicines called tricyclic antidepressants. WHAT ANAFRANIL IS USED FOR Anafranil is used to treat depression and mood disorders. Other psychological conditions that can be treated with Anafranil are obsessions, panic states and phobias (irrational fears), chronic painful conditions and muscular weakness (cataplexy) associated with repeat attacks of extreme sleepiness (narcolepsy) in adults. In children aged above 5 years, Anafranil is used to treat obsessions and bed-wetting. HOW ANAFRANIL WORKS Anafranil is believed to work either by increasing the amount of naturally occurring chemical messengers (noradrenaline and serotonin) in the brain or by making their effects last longer. If you have any questions about how Anafranil works or why this medicine has been prescribed for you, ask your doctor. 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE ANAFRANIL It is important to tell your doct Read the complete document
ANAFRANIL ® (CLOMIPRAMINE) 10MG, 25MG COATED TABLETS 75MG SUSTAINED-RELEASE TABLET SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT ANAFRANIL® 10mg, 25mg coated tablets; 75 mg sustained-release tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE The active ingredient is 3-Chloro-5-[3-(dimethylamino)-propyl]10,11-dihydro-5H-dibenz- [b,f]azepine hydrochloride (clomipramine hydrochloride). One coated tablet contains 10 mg or 25 mg clomipramine hydrochloride. One sustained-release tablet (divisible and non-divisible) contains 75 mg clomipramine hydrochloride. ACTIVE MOIETY Clomipramine EXCIPIENTS For the full list of excipients, please see section 6.1 3. PHARMACEUTICAL FORM Coated tablets (Anafranil® 10, Anafranil 25) Sustained-release tablets, divisible (Anafranil SR 75 Divitabs) 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS ADULTS Treatment of depressive states of varying aetiology and symptomatology, e.g. • endogenous, reactive, neurotic, organic, masked, and involutional forms of depression, • depression associated with schizophrenia and personality disorders, • depressive syndromes due to presenility or senility, to chronic painful conditions, and to chronic somatic diseases, depressive mood disorders of a reactive, neurotic, or psychopathic nature. Obsessive-compulsive syndromes. 3 Phobias and panic attacks. Cataplexy accompanying narcolepsy. Chronic painful conditions. CHILDREN AND ADOLESCENTS Nocturnal enuresis (only in patients over the age of 5 years and if organic causes have been excluded). No experience is available in children younger than 5 years of age. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Before initiating treatment with Anafranil, hypokalaemia should be treated (see section 4.4 Special warnings and precautions for use). The dosage should be adapted to the individual patient's condition. The aim is to achieve an optimum effect while keeping the doses as low as possible and increasing them cautiously. After a response has been obtained, mainten Read the complete document